Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mirvie
NCT07015203 · Preeclampsia (PE), Fetal Growth Restriction, and more
NCT07192393 · Prematurity; Extreme, Prematurity; Decision Support, and more
NCT05966649 · Preterm Spontaneous Labor With Preterm Delivery, Preterm Birth, and more
NCT06723392 · Preterm Birth, Small for Gestational Age (SGA), and more
NCT05229666 · Preterm Birth, Inflammation, and more
University of California San Diego
San Diego, California
Women's Care Florida
Orlando, Florida
Ochsner Health System
New Orleans, Louisiana
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions